𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Novel tumor antigens identified by autologous antibody screening of childhood medulloblastoma cDNA libraries

✍ Scribed by Uta Behrends; Inken Schneider; Sabine Rössler; Heinrich Frauenknecht; Anja Golbeck; Brigitte Lechner; Gerhard Eigenstetter; Colette Zobywalski; Stephan Müller-Weihrich; Ulrike Graubner; Irene Schmid; Dieter Sackerer; Manfred Späth; Claudia Goetz; Franz Prantl; Hans-Peter Asmuss; Karl Bise; Josef Mautner

Book ID
102271488
Publisher
John Wiley and Sons
Year
2003
Tongue
French
Weight
192 KB
Volume
106
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Medulloblastoma is an embryonal childhood malignancy with poor prognosis. By screening 4 medulloblastoma cDNA expression libraries (SEREX) with autologous sera, 15 different antigens were identified. These antigens were encoded by 3 novel genes, genes of unknown function (KIAA0445, KIAA1853, KIAA0665, FLJ13942, HSPC213), a proto‐oncogene (rab18), candidate tumor suppressor genes (BAP1, PRDM13) and genes encoding a motor protein (kinesin‐2), a histone (H2A1.2), the ankyrin residue‐rich nasopharyngeal cancer susceptibility protein (NZ16) and the transcription factor TZP, which is homologous to the tumor‐associated antigens HCA58 and GLEA2. In a consecutive analysis of serum antibody titers and tumor load, a more than 10‐fold increase in serum antibodies against PRDM13 preceded the clinical diagnosis of recurrent tumor growth in a patient with aggressive large cell medulloblastoma. When sera of pediatric patients with cancer (n = 40) and healthy controls (n = 40) were tested for humoral responses against the SEREX‐defined antigens, 5 antigens were exclusively recognized by sera from cancer patients. These antigens included a novel rab18 gene product translated from mRNA sequences formerly described as 3′ untranslated region. Humoral responses against 2 of the remaining 10 antigens were found preferentially in cancer patients. Antibodies against these antigens were detected in 8/40 and 12/40 cancer patients, respectively, but in only 1 healthy control. The 2 antigens were characterized by a tumor‐specific deletion and a tumor‐specific mutation, respectively. These findings indicate that the humoral immune response against medulloblastoma is directed against diverse antigens that may be useful as diagnostic markers or targets for immunotherapy. © 2003 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Identification of tumor-associated antig
Identification of tumor-associated antigens by screening phage-displayed human cDNA libraries with sera from tumor patients
✍ Olga Minenkova; Andrea Pucci; Emiliano Pavoni; Amedeo De Tomassi; Paola Fortugno 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 268 KB

## Abstract Screening cDNA libraries from solid human tumors with sera of autologous patients (SEREX) has proven to be a powerful approach to identifying tumor antigens recognized by the humoral arm of the immune system. In many cases, application of this methodology has led to the discovery of nov

Novel products of the HUD, HUC, NNP-1 an
Novel products of the HUD, HUC, NNP-1 and α-internexin genes identified by autologous antibody screening of a pediatric neuroblastoma library
✍ Uta Behrends; Thomas Jandl; Anja Golbeck; Brigitte Lechner; Stephan Müller-Weihr 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 274 KB

Autologous serological screening of a cDNA expression library (SEREX) derived from childhood neuroblastoma led to the identification of 10 different antigens, including 6 novel gene products. The novel antigen 018INX was derived from a small open reading frame in a region of alpha-internexin mRNA th